Kropotova Alexandra 4
4 · SAB Biotherapeutics, Inc. · Filed Dec 31, 2024
Insider Transaction Report
Form 4
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-12-18−9,072→ 48,428 total
Footnotes (3)
- [F1]Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
- [F2]Includes 21,712 shares of Common Stock and 26,716 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
- [F3]Each RSU represents a contingent right to receive one share of Common Stock.